ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Induction therapy"

  • 2021 American Transplant Congress

    Single-Dose Basiliximab Induction Therapy in Low-Immunologic Risk Kidney Transplant Recipients

    A. Hutchins, J. Schoen, J. S. McMullen

    Pharmacy, Nebraska Medicine, Omaha, NE

    *Purpose: The purpose of this study is to examine the outcomes associated with single-dose basiliximab in low-immunologic risk kidney transplant recipients following a revision to…
  • 2021 American Transplant Congress

    Primary Graft Dysfunction in a Risk-Stratified vs. Routine Induction Protocol in Heart Transplant Recipients

    J. S. van Zyl1, H. Zafar1, P. M. Nguyen2, J. Felius1, T. Sam3, S. A. Hall3

    1Baylor Scott & White Research Institute, Dallas, TX, 2Texas A&M University College of Medicine Health Science Center, Dallas, TX, 3Baylor Scott & White Health, Dallas, TX

    *Purpose: Treatment of left ventricular primary graft dysfunction (PGD-LV) is supportive in nature. We aim to evaluate whether a change in induction protocol from a…
  • 2021 American Transplant Congress

    Impact of Induction Immunosuppression Selection on Clinical Outcomes in Kidney Transplant Recipients During the COVID-19 Pandemic in New York City

    K. Khalil, S. Jonchhe, J. Stern, T. C. Lewis, N. Alnazari, B. Lonze, Z. Stewart Lewis, N. Ali

    Transplant Institute, NYU Langone Health, New York, NY

    *Purpose: As an early epicenter in the coronavirus pandemic, our center modified induction immunosuppression strategies for transplantation. We sought to determine if changes in induction…
  • 2021 American Transplant Congress

    Cost Savings Initiative with Idea Body Weight Dosing of Rabbit Anti-thymocyte Globulin (rATG) Induction in an Older Kidney Transplant Population: A Single Center Analysis

    C. LaFratte1, S. Witek1, D. Sawinski2, J. Trofe-Clark2, C. Sammons2, B. Hardek1, R. Samudralwar1, A. Forte1, S. Lyle1, J. Rashid1, G. Malat2

    1Pharmacy, Hospital of Univ of Pennsylvania, Philadelphia, PA, 2Penn Transplant Institute, Hospital of Univ of Pennsylvania, Philadelphia, PA

    *Purpose: Optimal dosing schemes for rATG induction are not well defined for older kidney transplant recipients (KTRs), who are at greater risk for adverse events…
  • 2021 American Transplant Congress

    The Impact of Fixed-Dose Alemtuzumab in Renal Transplant Recipients According to Weight

    S. Mandala1, N. Khodieva2, A. Bigness1, S. Mohamed2, H. Mohammed1, K. Robichaux2, A. Brueckner3, R. Baliga4, J. Buggs5, A. Kumar1, L. Bowman3

    1Morsani College of Medicine, University of South Florida, Tampa, FL, 2Honors College, University of South Florida, Tampa, FL, 3Transplant Pharmacy, Tampa General Hospital, Tampa, FL, 4Nephrology, Florida Kidney Physicians, Tampa, FL, 5Transplant Surgery, Tampa General Hospital, Tampa, FL

    *Purpose: Alemtuzumab, a potent anti-CD52 monoclonal antibody is used for induction immunosuppression post-renal transplantation as a fixed 30mg dose regardless of the patient’s weight. The…
  • 2021 American Transplant Congress

    Preemptive Second Kidney Transplant Outcomes by Induction Type in the United States

    S. Riad1, G. Larrieux2, S. Jackson3, R. Kandaswamy2

    1Medicine, University of Minnesota, Minneapolis, MN, 2Surgery, University of Minnesota, Minneapolis, MN, 3Complex Care Analytics, M-Health Fairview, Minneapolis, MN

    *Purpose: Failed kidney allograft is the fourth leading indication for kidney transplantation. A significant portion of second kidney transplant recipients undergo preemptive transplantation while on…
  • 2021 American Transplant Congress

    Outcomes of Second Kidney Transplant After Return to Dialysis by Induction Type in the United States

    S. Riad1, T. Shaker1, S. Jackson2, R. Kandaswamy3

    1Medicine, University of Minnesota, Minneapolis, MN, 2Complex Care Analytics, M-Health Fairview, Minneapolis, MN, 3Surgery, University of Minnesota, Minneapolis, MN

    *Purpose: A failed kidney allograft is the 4th leading indication for kidney transplantation. We examined the association of induction use in 2nd kidney transplant recipients…
  • 2021 American Transplant Congress

    Outcomes in Standard vs. Extended Use of Thymoglobulin as Induction Therapy in Kidney Transplant Recipients

    N. M. Sifontis1, A. Coleman1, D. Tang1, K. Lau2, S. Karhadkar2, A. DiCarlo2, A. Diamond2

    1Temple University School of Pharmacy, Philadelphia, PA, 2Temple University Health System, Philadelphia, PA

    *Purpose: Thymoglobulin induction along with modern maintenance immunosuppression has been found to have a significant reduction in acute rejection in kidney transplantation. The recommended duration…
  • 2021 American Transplant Congress

    Sirolimus (srl) versus Everolimus (evr) versus Mycophenolate (mpa) in Kidney Transplant Recipients Receiving Anti-thymocyte Globulin Induction (r-atg), Tacrolimus (tac), and Prednisone

    H. Tedesco Silva Junior, C. Felipe, L. Viana, M. Cristelli, N. Tenorio, V. Lima, V. Azevedo, K. Ficher, J. Rezende, R. Foresto, M. Nakamura, Y. Dreige, J. Taddeo, C. Zito, J. Medina

    Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil

    *Purpose: The aim of this study is to compare the efficacy and safety of SRL versus EVR versus MPA in kidney transplant recipients.*Methods: This is…
  • 2020 American Transplant Congress

    Outcome of Induction Therapies in Low Sensitized Renal Transplant Recipients with Two HLA DR Mismatch in Tacrolimus Era

    K. Soliman1, T. Fulop1, A. Osman2, H. Ali3

    1Medicine, Medical University of South Carolina, Charleston, SC, 2Medicine, Cairo University, Cairo, Egypt, 3Medicine, Royal Stoke, Royal Stoke, United Kingdom

    *Purpose: A mismatch for two HLA DR antigens portends high immunological risk in renal transplant recipients (RTRs). Induction therapies with both rabbit Anti-thymocyte Globulin (r-ATG)…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 31
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences